The supply of controlled medicines is subject to strict regulatory requirements, which require authorization from both the importing and exporting countries.
The development and production of BPT products in a pharmaceutical context (clinical trials, production requirements, marketing authorization procedures...) requires time.
This article reviews the European Medicines Agency requirements for authorization, the Spanish legal framework and controversies on BS and presents the position paper of the Spanish Society of Rheumatology on these drugs.
The NPCF plays an important role in defining the requirements regarding authorization and security of the EPR as well as for the legal framework in which optimal use can be made of the EPR.
Recommendation Researchers should ensure that they can retrieve genomic data and that a CSP cannot retain it or use it after the contract ends, subject to legal or regulatory requirements and/or authorization of the researchers.
Researchers should ensure that they can retrieve genomic data and that a CSP cannot retain it or use it after the contract ends, subject to legal or regulatory requirements and/or authorization of the researchers.
L. 109 163, § 815(d)(1), substituted "Requirement for authorization by law of certain contracts relating to vessels, aircraft, and combat vehicles" for "Requirement for authorization by law of certain contracts relating to vessels and aircraft" in section catchline.
3382, substituted "Requirement for authorization by law of certain contracts relating to vessels, aircraft, and combat vehicles" for "Requirement for authorization by law of certain contracts relating to vessels and aircraft" in item 2401.
Requirement of authorization to import.
§ 1312.11 Requirement of authorization to import.
21 CFR § 1312.11 - Requirement of authorization to import.
